Gene · 1390
Papers1,658
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,658
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Gene-Based Rare Variant Burden Analyses Across Biobanks Identify Novel High-Risk Genes for Thoracic Aortic Disease. | medRxiv | 2026 | 42818172 | PubTator, text mining | PubMed |
| A comprehensive full-length transcriptome landscape of cigarette smoke-exposed HASMCs reveals extensive remodeling of mRNA isoforms and regulatory networks. | PLoS One | 2026 | 42766668 | PubTator, text mining | PubMed |
| Aging microenvironment induces CD8+ T cell exhaustion by suppressing hepatic β-hydroxybutyrylate synthesis. | Cell Metab | 2026 | 42692017 | PubTator, text mining | PubMed |
| CREM Marks TCR-Driven T-Cell Activation and Associates with Favorable Prognosis in Papillary Thyroid Carcinoma: A Single-Cell and Bulk Transcriptomic Study. | Int J Mol Sci | 2026 | 42653390 | PubTator, text mining | PubMed |
| CRTC, not phosphorylated CREB1, drives cAMP-induced transcription across diverse cell types. | bioRxiv | 2026 | 42619677 | PubTator, text mining | PubMed |
| PGE2-mediated NK cell reprogramming drives acquired immunotherapy resistance in lung adenocarcinoma. | J Immunother Cancer | 2026 | 42586608 | PubTator, text mining | PubMed |
| Immune cells harbor their own microbiome-derived metabolome: a new layer of immunometabolic regulation. | Front Immunol | 2026 | 42582102 | PubTator, text mining | PubMed |
| The CREM-IL-15 axis: decoding the persistence-exhaustion paradox in NK cell immunotherapy. | Cancer Immunol Immunother | 2026 | 42550263 | PubTator, text mining | PubMed |
| Clinicopathologic characteristics of uterine malignant epithelioid neoplasms with EWSR1::CREM fusion: Report of 2 cases at a novel site with literature review. | Virchows Arch | 2026 | 42360471 | PubTator, text mining | PubMed |
| [Cutaneous clear cell sarcoma]. | Pathologie (Heidelb) | 2026 | 42307723 | PubTator, text mining | PubMed |
| β-Adrenergic receptors as immunomodulators in T cells: mechanisms of neuroimmune crosstalk and pathophysiological implications. | Mol Med | 2026 | 42298399 | PubTator, text mining | PubMed |
| The influence of unhealthy lifestyle on semen quality: results from a cross-sectional study and Mendelian randomization analysis. | Ann Med Surg (Lond) | 2026 | 42254241 | PubTator, text mining | PubMed |
| Melatonin Alleviates Graft Biliary Fibrosis by Inhibiting VIM+ Cholangiocyte Subcluster via Hypoxia/TGF-β-CREM-VIM Axis. | Adv Sci (Weinh) | 2026 | 42234402 | PubTator, text mining | PubMed |
| Spinal EWSR1::CREM fused mesenchymal tumor: an extracranial CNS counterpart of intracranial mesenchymal tumor, FET::CREB‑fusion positive. | Brain Tumor Pathol | 2026 | 42230517 | PubTator, text mining | PubMed |
| The cAMP response element modulator (CREM) in ulcerative colitis: Molecular mechanisms and therapeutic potential. | Biochem Pharmacol | 2026 | 42173408 | PubTator, text mining | PubMed |
| Paternal Sertoli cell-derived extracellular vesicles transfer mtDNA and microRNA cargo to trigger germ cell oxidative stress and induce metabolic risks in offspring. | Cell Commun Signal | 2026 | 42098702 | PubTator, text mining | PubMed |
Malignant epithelioid mesenchymal neoplasms with EWSR1/FUS::CREM fusions: clinicopathological and molecular genetic analysis of seven cases highlighting immunophenotypic heterogeneity, frequent aggressive behaviour, and diagnostic pitfalls. | Histopathology | 2026 | 42023520 | PubTator, text mining | PubMed |
| Primary pulmonary myxoid sarcoma: expanding the EWSR1 fusion spectrum with a novel CREM partner. | Pathology | 2026 | 42020284 | PubTator, text mining | PubMed |
| A CREM-ITGA2B-MAPK axis drives proliferation and invasiveness in gastric cancer: insights from single-cell analysis. | Cell Oncol (Dordr) | 2026 | 41944931 | PubTator, text mining | PubMed |
| Cytomegalovirus Drives the Development of Cytotoxic CD4+ T Cells in Patients With Multiple Sclerosis. | Neurol Neuroimmunol Neuroinflamm | 2026 | 41871309 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1390/papers